GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,027,000 | +102.4% | 279,400 | -5.0% | 0.02% | +109.1% |
| Q2 2022 | $9,401,000 | +1926.1% | 294,245 | +2095.5% | 0.01% | – |
| Q1 2022 | $464,000 | -66.1% | 13,402 | -71.4% | 0.00% | -100.0% |
| Q4 2021 | $1,370,000 | -16.9% | 46,823 | -27.6% | 0.00% | 0.0% |
| Q3 2021 | $1,648,000 | +34.2% | 64,656 | +128.0% | 0.00% | 0.0% |
| Q4 2020 | $1,228,000 | -78.4% | 28,355 | -72.5% | 0.00% | -83.3% |
| Q3 2020 | $5,680,000 | -57.2% | 103,022 | -51.0% | 0.01% | -62.5% |
| Q2 2020 | $13,263,000 | -28.2% | 210,100 | -41.9% | 0.02% | -44.8% |
| Q1 2020 | $18,482,000 | +57.0% | 361,735 | +144.3% | 0.03% | +123.1% |
| Q4 2019 | $11,772,000 | -29.5% | 148,100 | -57.0% | 0.01% | -38.1% |
| Q3 2019 | $16,694,000 | +174.0% | 344,047 | +197.0% | 0.02% | +162.5% |
| Q2 2019 | $6,093,000 | +69.4% | 115,841 | +70.5% | 0.01% | +60.0% |
| Q1 2019 | $3,596,000 | +74.2% | 67,923 | +35.1% | 0.01% | +66.7% |
| Q4 2018 | $2,064,000 | +169.5% | 50,261 | +149.4% | 0.00% | +200.0% |
| Q3 2018 | $766,000 | +189.1% | 20,150 | +266.8% | 0.00% | – |
| Q1 2018 | $265,000 | -63.2% | 5,494 | -70.0% | 0.00% | -100.0% |
| Q4 2017 | $720,000 | -62.1% | 18,297 | -77.8% | 0.00% | -66.7% |
| Q3 2016 | $1,899,000 | +638.9% | 82,374 | +431.4% | 0.00% | – |
| Q2 2016 | $257,000 | +0.4% | 15,500 | -4.0% | 0.00% | – |
| Q1 2016 | $256,000 | – | 16,142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |